Early Detection Research Network

Intergrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery

The overall objective is to validate serum protein markers for early diagnosis of ovarian cancer with the ultimate goal being to develop a multiparametric panel consisting of 2-4 novel markers with 10 known markers for phase 3 analysis. In phase 1, we will screen for markers able to pass a threshold of 98% specificity and 30% sensitivity in a cohort of 300 women. Markers that pass phase 1 validation will be investigated in a phase 2 PRoBE cohort with a 98% specificity and 70% sensitivity cut-off. Finally, markers that pass phase 2 validation will be evaluated in EDRN CVC laboratory specimens with a cut-off of > 98% specificity and 90% sensitivity.
405-intergrated-systems-biology-approach-for-ovarian
8a3fb716d6de42449a6a82a99f359e2a
8a3fb716d6de42449a6a82a99f359e2a
Contents

There are currently no items in this folder.